Cocrystal Pharma, Inc.
COCP
$1.04
$0.032.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -14.97% | -17.50% | |||
| Gross Profit | 14.97% | 17.50% | |||
| SG&A Expenses | 15.11% | 0.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.90% | -9.95% | |||
| Operating Income | 0.90% | 9.95% | |||
| Income Before Tax | 0.29% | 10.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.29% | 10.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.29% | 10.69% | |||
| EBIT | 0.90% | 9.95% | |||
| EBITDA | 0.53% | 9.89% | |||
| EPS Basic | 7.72% | 10.70% | |||
| Normalized Basic EPS | 7.69% | 10.75% | |||
| EPS Diluted | 7.72% | 10.70% | |||
| Normalized Diluted EPS | 7.69% | 10.75% | |||
| Average Basic Shares Outstanding | 8.03% | 0.00% | |||
| Average Diluted Shares Outstanding | 8.03% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||